Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap: |
Title | Respira |
Description | Home About Us Unmet Needs Science & Technology Pipeline Scientific Publications Press Releases RESPIRATORY TREATMENT INNOVATION . . . . . . Respira is dev |
Keywords | N/A |
WebSite | respiratherapeutics.com |
Host IP | 66.147.242.195 |
Location | United States |
Site | Rank |
US$6,451,082
Last updated: 2023-05-09 00:33:47
respiratherapeutics.com has Semrush global rank of 1,640,702. respiratherapeutics.com has an estimated worth of US$ 6,451,082, based on its estimated Ads revenue. respiratherapeutics.com receives approximately 744,356 unique visitors each day. Its web server is located in United States, with IP address 66.147.242.195. According to SiteAdvisor, respiratherapeutics.com is safe to visit. |
Purchase/Sale Value | US$6,451,082 |
Daily Ads Revenue | US$5,955 |
Monthly Ads Revenue | US$178,646 |
Yearly Ads Revenue | US$2,143,745 |
Daily Unique Visitors | 49,624 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
respiratherapeutics.com. 7200 | A | respiratherapeutics.com. 7200 | IP: 66.147.242.195 |
respiratherapeutics.com. 7200 | NS | respiratherapeutics.com. 7200 | NS Record: ns40.worldnic.com. |
respiratherapeutics.com. 7200 | NS | respiratherapeutics.com. 7200 | NS Record: ns39.worldnic.com. |
respiratherapeutics.com. 7200 | MX | respiratherapeutics.com. 7200 | MX Record: 20 mx2-us2.ppe-hosted.com. |
respiratherapeutics.com. 7200 | MX | respiratherapeutics.com. 7200 | MX Record: 10 mx1-us2.ppe-hosted.com. |
respiratherapeutics.com. 3600 | TXT | respiratherapeutics.com. 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
Home About Us Unmet Needs Science & Technology Pipeline Scientific Publications Press Releases RESPIRATORY TREATMENT INNOVATION . . . . . . Respira is developing next-generation cardiopulmonary disease-targeted inhalation products. Our advanced particle engineering and formulation approaches in combination with our proprietary device technologies are designed to enhance drug delivery to the lung periphery. Our Science We are pioneering respiratory therapies for patients with pulmonary arterial hypertension (PAH) . . . . . . Our therapies are intended to provide acute relief from the most common symptoms of breathlessness and fatigue. Unmet Needs Phase 2 clinical trials of our leading pipeline candidate are underway . . . . . . Respira’s lead drug-device product candidate, RT234-PAH, is a first-in-class inhaled therapy intended for “as-needed” use by patients (PRN). OUR PIPELINE Learn more about our Phase 2B clinical trial in PAH [here] Leading the fight for breath . . . . . . Our |
HTTP/1.1 200 OK Date: Sat, 30 Oct 2021 23:23:31 GMT Server: Apache Upgrade: h2,h2c Connection: Upgrade host-header: c2hhcmVkLmJsdWVob3N0LmNvbQ== Content-Type: text/html; charset=UTF-8 |
Domain Name: RESPIRATHERAPEUTICS.COM Registry Domain ID: 1607512271_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2018-07-09T15:50:25Z Creation Date: 2010-07-21T13:11:02Z Registry Expiry Date: 2023-07-21T13:11:02Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS39.WORLDNIC.COM Name Server: NS40.WORLDNIC.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-18T09:42:17Z <<< |